MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Parkinsonism in a movement disorder reference center in El Salvador

    D. Pereira (San Salvador, El Salvador)

    Objective: To describe the frequency of Parkinson's disease and parkinsonism in a movement disorder reference center in El Salvador. Background: El Salvador is a  country…
  • 2019 International Congress

    Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

    T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)

    Objective: To compare single-photon emission computed tomography (SPECT) with [123I]FP-CIT and positron emission tomography (PET) with [11C]PE2I as markers of dopamine transporter (DAT) loss in…
  • 2019 International Congress

    Appendectomy and risk of Parkinson’s disease: A meta-analysis using real-world evidence

    S. Hussain, A. Najmi (New Delhi, India)

    Objective: This meta-analysis is aimed to explore the association between appendectomy and Parkinson’s disease (PD) risk. Background: Parkinson’s disease is recently recognized as a systematic…
  • 2019 International Congress

    Differential effects of stimulation amplitude and lead laterality of deep brain stimulation of the subthalamic nucleus on speech and Parkinsonian motor symptoms

    E. Tripoliti, B. Veggia, M. Hariz, P. Limousin (Reggio Emili, Italy)

    Objective: To examine the differential effects of subthalamic nucleus deep brain stimulation (STN DBS) amplitude (high and low) and lead laterality (Left-Right-bilateral) on speech intelligibility…
  • 2019 International Congress

    Inspiring Neurology Residents to Select Movement Disorders Fellowship Training

    K. Harper, T. Davis, F. Phibbs, PD. Charles (Nashville, TN, USA)

    Objective: To measure the impact of a junior resident education course focused on common movement disorders. Background: Focus on Common Movement Disorders is a two-day…
  • 2019 International Congress

    Actigraphically Characterized Infradian Rest-Activity Rhythms in Parkinson’s Disease

    C. Brooks, R. Koehler, MK. Erb, F. Mortazavi, J. Bhangu, K. Thomas (Boston, MA, USA)

    Objective: To characterize infradian variations across the week in participants with Parkinson’s disease (PD), preliminary analyses were conducted as a means to develop a process…
  • 2019 International Congress

    Comparison of autonomic symptoms on Parkinson’s disease and essential tremor with SCOPA-AUT

    J. Gonzalez (Lima, Peru)

    Objective: To compare the presence of autonomic symptoms on Parkinson's disease (PD) and essential tremor (ET) applying the Scale for Outcomes in Parkinson’s disease for…
  • 2019 International Congress

    Phosphodiesterase 10A and cognition in Parkinson’s disease

    Z. Chappell, G. Pagano, H. Wilson, F. Niccolini, R. Gunn, E. Rabiner, T. Foltynie, M. Politis (London, United Kingdom)

    Objective: We aimed to assess the associations between Phosphodiesterase 10A (PDE10A) expression in the executive striatum and cognitive performance in vivo, using [11C]IMA107 PET and…
  • 2019 International Congress

    Primary disruption of the subsystems of the default mode network in drug-naïve Parkinson’s disease with mild cognitive impairments: a resting-state functional connectivity MRI study

    YB. Hou, QQ. Wei, RW. Ou, J. Yang, W. Song, QY. Gong, HF. Shang (Chengdu, China)

    Objective: To study changes in subsystems in drug-naïve Parkinson’s disease with mild cognitive impairments using resting-state functional connectivity MRI. Background: Mild cognitive impairment (MCI) is common…
  • 2019 International Congress

    Is 18F-FDG-PET/CT a helpful tool to diagnose PSP clinical variants?

    G. Marti-Andres, M. Riverol-Fernandez, R. Valentí-Azcárate, M. Fernández-Matarrubia, E. Prieto-Azcárate, J. Arbizu-Azcarate, MR. Luquin-Piudo (Pamplona, Spain)

    Objective: To assess if there are differential metabolic brain patterns among Progressive Supranuclear Palsy(PSP) clinical variants and between them and Parkinson’s disease patients (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley